About Duality Biologics

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
Shanghai, CN
Description
Information
About Duality Biologics Duality Bio is a global clinical stage biotech to develop next generation ADC and bispecific for oncology and autoimmune diseases. Founded by serial entrepreneurs and backed by well-known investors (Lilly Asia Venture, 6 Dimension Capital and WuXi Biologics) with $110 million fund raising, Duality Bio has established top notch ADC platforms and built a novel pipeline including more than 10 Best-in-Class and First-in-Class bispecific antibody and Antibody-Drug Conjugate (ADC) drugs. CONTACT US: [email protected] 关于映恩生物 “交映生辉,恩泽生命”。映恩生物由行业知名投资人朱忠远博士在2020年1月创立,致力于开发创新分子类型药物(novel modality drugs)。公司聚焦肿瘤及自身免疫疾病领域,打造了近10款Best-in-class及First-in-class的抗体偶联药物(ADC) 和双特异性抗体药物,其中多款药物处于IND申报阶段。公司深耕ADC药物的创新研发,并成功建立了多条具有自主知识产权的下一代 ADC技术平台,持续推动多款ADC药物进入临床及商业化应用。映恩生物拥有一支具有国际化视野的核心创业团队,公司在中美两地运营,研发团队曾领导参与了 50多款肿瘤及自身免疫药物的全球临床开发,其中5款创新药物在中国和美国获批上市。映恩生物将持续通过自主研发及战略合作的双轮驱动模式,建立丰富产品管线,造福患者。 联络我们: [email protected]

Duality Biologics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology

Frequently Asked Questions about Duality Biologics

What is Duality Biologics email format?

The widely used Duality Biologics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Duality Biologics customer service number?

To contact Duality Biologics customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more